Actavia Life Sciences 

$0.000500
1
-$0.00-0% Thursday 13:30

Statistics

Day High
0.0005
Day Low
0.0005
52W High
0.004
52W Low
0.0005
Volume
20
Avg. Volume
-
Mkt Cap
385,905.52
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.04
-0.03
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0018

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-8.89MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RASP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Show more...
CEO
Ms. Keeren Shah
Employees
1
Country
United States
ISIN
US7538881068

Listings

0 Comments

Share your thoughts

FAQ

What is Actavia Life Sciences stock price today?
The current price of RASP is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch Actavia Life Sciences stock price performance more closely on the chart.
What is Actavia Life Sciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Actavia Life Sciences stocks are traded under the ticker RASP.
Is Actavia Life Sciences stock price growing?
RASP stock has fallen by -0% compared to the previous week, the month change is a -0% fall, over the last year Actavia Life Sciences has showed a -87.5% decrease.
What is Actavia Life Sciences market cap?
Today Actavia Life Sciences has the market capitalization of 385,905.52
What were Actavia Life Sciences earnings last quarter?
RASP earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Actavia Life Sciences revenue for the last year?
Actavia Life Sciences revenue for the last year amounts to 0 USD.
What is Actavia Life Sciences net income for the last year?
RASP net income for the last year is -8.89M USD.
How many employees does Actavia Life Sciences have?
As of June 20, 2026, the company has 1 employees.
In which sector is Actavia Life Sciences located?
Actavia Life Sciences operates in the Health & Wellness sector.
When did Actavia Life Sciences complete a stock split?
The last stock split for Actavia Life Sciences was on September 20, 2016 with a ratio of 3.25:1.
Where is Actavia Life Sciences headquartered?
Actavia Life Sciences is headquartered in New York, United States.